Changes this week
Changes detected in the 7 days to Nov 21, 2026
- Minor: Osseodensification Versus Osteotome Internal Sinus Lifting in Delayed Implant Placement Primary completion pushed from Mar 21, 2027 to Aug 21, 2027
- Minor: Treating New Learning and Memory Deficits Following Stroke Primary and study completion pushed from Oct 2026 to Dec 2026
- Minor: Case Management Dyad Primary completion pushed from Sep 30, 2026 to Nov 30, 2026
- Minor: Tap Trust Intervention on Water Security Experiences and Beverage Intake Primary completion pushed from Jul 2027 to Sep 30, 2027
- Minor: Acoustic Stimulation During Sleep: Effects on Memory and p-tau217 in MCI Primary completion pushed from Sep 2027 to Dec 2027
- Minor: Changes in Perioperative Blood Volume and Fluid Distribution in Patients Undergoing Primary Total Hip Replacement Primary and study completion pushed from Sep 2026 to Dec 2026
- Minor: Symptoms, Respiratory Dysfunction and Frailty Level in Allergic and Eosonophilic Asthmatics Primary completion pushed from Oct 30, 2026 to Mar 30, 2027
- Minor: Diabetes Prevention by Group Intervention and CGM Use in Pre-diabetic Adults Primary completion pushed from Nov 2026 to Mar 2027
- Minor: Using EMA Data to Inform a Web-intervention for Couples Concerned About Drinking Primary completion pushed from Aug 2026 to Dec 2026
- Minor: High-Flow Tracheal Therapy on Tracheobronchial Secretions in Tracheostomized Patients Primary completion pushed from Aug 1, 2027 to Jan 1, 2028
- Minor: Impact of Keratinized Mucosa Augmentation on Treatment Outcomes of Peri-implant Mucositis Primary completion pushed from Sep 10, 2026 to Dec 10, 2026
- Minor: Detection of Microplastics · Periodontitis Primary completion pushed from Feb 1, 2027 to Jul 1, 2027
- Minor: Integrated Grief Therapy on Psychological Resilience, Post-Traumatic Growth, Traumatic Stress, and Grief Processes in Earthquake Survivors Primary completion pushed from Aug 1, 2026 to Dec 1, 2026
- Minor: Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) · Muscle Invasive Bladder Cancer (EV-309) Trial sites expanded: 29 → 37 locations
- Minor: NBI-1065845-MDD3026 · Osavampator as an Adjunctive Treatment · Major Depressive Disorder (MDD) Trial sites expanded: 35 → 39 locations
- Minor: Denifanstat · Moderate to Severe Acne (AURORA) Trial sites expanded: 28 → 35 locations
- Minor: NBI-1065845-MDD3025 · Osavampator as an Adjunctive Treatment · Major Depressive Disorder (MDD) Trial sites expanded: 39 → 42 locations
- Minor: Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine · Acute Myeloid Leukemia (AML) Trial sites expanded: 36 → 40 locations
- Minor: Osavampator as an Adjunctive Treatment · Major Depressive Disorder (MDD) Trial sites expanded: 18 → 30 locations
- Minor: Oral Pyridoxal 5'-Phosphate · PNPO Deficiency Trial sites expanded: 7 → 10 locations
- Minor: Tividenofusp Alfa (DNL310) · Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007 Trial sites expanded: 29 → 32 locations
- Minor: VER-01 · Chronic Painful Lumbosacral Radiculopathy Trial sites expanded: 40 → 43 locations
- Minor: Vonoprazan 10 mg Compared to Placebo for Relief of Episodic Heartburn · Symptomatic Non-Erosive Gastroesophageal Reflux Disease Through 24 Weeks Trial sites expanded: 0 → 26 locations
- Minor: FORTIFI-HN01 · Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC Trial sites expanded: 231 → 242 locations
- Minor: Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination · a KRAS G12C Mutation KRYSTAL-7 Trial sites expanded: 770 → 776 locations
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates